OFG
COCH icon

OTA Financial Group’s Envoy Medical COCH Stock Holding History

OTA Financial Group’s Portfolio COCH Stock Details COCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-36,271
Closed -$356K – 78
2022
Q3 		$356K Buy
36,271
+13,598
+60% +$134K 0.31% 46
2022
Q2 		$222K Buy
+22,673
New +$222K 0.11% 84

Other funds holding COCH

AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
FTCM
Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return

OTA Financial Group's COCH Position: Q4 2022 in Review

OTA Financial Group sold out of Envoy Medical (COCH) in Q4 2022, closing a stake of 36,271 shares — an estimated $356K sold.

OTA Financial Group first reported a position in COCH in Q2 2022 and held it in 2 quarters. The position peaked at $356K in Q3 2022. 93 funds tracked by Wall St. Rank hold COCH as of Q4 2022.

  • OTA Financial Group reported no remaining Envoy Medical position as of Q4 2022 after selling out during the quarter.
  • OTA Financial Group sold 36,271 Envoy Medical shares in Q4 2022, an estimated $356K.
  • OTA Financial Group first reported a position in Envoy Medical in Q2 2022 and held it in 2 quarters.
  • OTA Financial Group's Envoy Medical position peaked at $356K in Q3 2022.
  • 93 funds tracked by Wall St. Rank held Envoy Medical as of Q4 2022.

Based on OTA Financial Group's 13F filing for Q4 2022, filed 9 Feb 2023.